New Blood Pressure-Lowering Peptide Found in Mackerel Using Computer Modeling
Using a QSAR computer model to screen mackerel muscle protein fragments, researchers discovered two novel ACE-inhibitory peptides, with PLITT showing strong activity (IC50: 48.73 μM) and excellent stability under heat, pH changes, and salt — making it a candidate for blood pressure-lowering functional foods.
Quick Facts
What This Study Found
The novel mackerel-derived peptide PLITT inhibits ACE with IC50 of 48.73 μM through mixed competitive/non-competitive mechanisms via hydrogen bonding, and remains stable under food processing conditions.
Key Numbers
Two novel peptides identified: LTPFT and PLITT; QSAR model based on 5z-scale metrics; molecular docking confirmed binding mechanisms.
How They Did This
Developed a QSAR model using 5z-scale descriptors to screen mackerel muscle hydrolysates for ACE-inhibitory peptides. Validated top candidates (LTPFT, PLITT) through in silico screening, molecular docking, enzyme kinetics, and stability testing under heat, pH, glucose, NaCl, and metal ion conditions.
Why This Research Matters
High blood pressure affects nearly half of adults worldwide and is a leading risk factor for heart disease and stroke. Finding stable, food-derived ACE inhibitors means people could potentially lower blood pressure through functional foods or supplements, complementing or even partially replacing pharmaceutical drugs with fewer side effects.
The Bigger Picture
This study exemplifies the convergence of computational screening with food science. Rather than randomly testing thousands of protein fragments, QSAR modeling dramatically narrows the search. The exceptional stability of PLITT under food processing conditions (heat, pH, salt) is particularly notable — many bioactive peptides lose activity during cooking or manufacturing. If PLITT survives digestion equally well, it could be a practical functional food ingredient.
What This Study Doesn't Tell Us
In vitro and computational study only — no human or animal blood pressure measurements. Whether enough PLITT survives digestion to reach the bloodstream at therapeutic concentrations is unknown. The IC50 of 48.73 μM, while respectable, means significant amounts would need to be consumed for a blood pressure effect.
Questions This Raises
- ?Does PLITT survive gastrointestinal digestion and maintain its ACE-inhibitory activity after absorption?
- ?What quantity of mackerel or supplemental PLITT would a person need to consume to achieve a meaningful blood pressure reduction?
- ?Could PLITT be combined with other food-derived ACE inhibitors for a synergistic effect?
Trust & Context
- Key Stat:
- IC50: 48.73 μM the novel mackerel peptide PLITT's potency for blocking ACE — and it remains stable under high heat, varying pH, and salt conditions relevant to food processing
- Evidence Grade:
- Preliminary — in vitro enzyme inhibition and computational modeling only. No animal or human blood pressure studies conducted. The peptide's bioavailability after oral consumption is unknown.
- Study Age:
- Published in 2024 in Food Chemistry, a leading journal for food bioactives and functional food research.
- Original Title:
- The novel angiotensin-I-converting enzyme inhibitory peptides from Scomber japonicus muscle protein hydrolysates: QSAR-based screening, molecular docking, kinetic and stability studies.
- Published In:
- Food chemistry, 447, 138873 (2024)
- Authors:
- Wang, Baobei, Zhang, Hui(5), Wen, Yuxi, Yuan, Wenwen, Chen, Hongbin, Lin, Luan, Guo, Fengxian, Zheng, Zong-Ping, Zhao, Chao
- Database ID:
- RPEP-09467
Evidence Hierarchy
Frequently Asked Questions
Could eating mackerel lower my blood pressure?
Mackerel protein contains peptides that can block ACE (the same enzyme targeted by blood pressure drugs) in the lab. However, when you eat mackerel, digestive enzymes break proteins into different fragments than those tested here, and it's unclear if enough ACE-blocking peptides survive digestion to reach your bloodstream. Fish consumption is associated with heart health benefits, but the specific blood pressure effect of these peptides needs human studies to confirm.
How does a QSAR model find peptides?
QSAR (Quantitative Structure-Activity Relationship) uses math to connect a molecule's physical and chemical features to its biological activity. The researchers fed the model data on known ACE-inhibiting peptides, and it learned which features predict strong inhibition. It then screened mackerel protein fragments to find new ones matching those features — like a smart filter that predicts winners before they're tested in the lab.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09467APA
Wang, Baobei; Zhang, Hui; Wen, Yuxi; Yuan, Wenwen; Chen, Hongbin; Lin, Luan; Guo, Fengxian; Zheng, Zong-Ping; Zhao, Chao. (2024). The novel angiotensin-I-converting enzyme inhibitory peptides from Scomber japonicus muscle protein hydrolysates: QSAR-based screening, molecular docking, kinetic and stability studies.. Food chemistry, 447, 138873. https://doi.org/10.1016/j.foodchem.2024.138873
MLA
Wang, Baobei, et al. "The novel angiotensin-I-converting enzyme inhibitory peptides from Scomber japonicus muscle protein hydrolysates: QSAR-based screening, molecular docking, kinetic and stability studies.." Food chemistry, 2024. https://doi.org/10.1016/j.foodchem.2024.138873
RethinkPeptides
RethinkPeptides Research Database. "The novel angiotensin-I-converting enzyme inhibitory peptide..." RPEP-09467. Retrieved from https://rethinkpeptides.com/research/wang-2024-the-novel-angiotensiniconverting-enzyme
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.